Literature DB >> 32150161

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection.

Christiaan R de Vries1, Johanna M Sweere2, Heather Ishak3, Vivekananda Sunkari4, Michelle S Bach4, Dan Liu4, Robert Manasherob4, Paul L Bollyky2.   

Abstract

Pseudomonas aeruginosa (P. aeruginosa) is a major nosocomial pathogen of increasing relevance to human health and disease, particularly in the setting of chronic wound infections in diabetic and hospitalized patients. There is an urgent need for chronic infection models to aid in the investigation of wound pathogenesis and the development of new therapies against this pathogen. Here, we describe a protocol that uses delayed inoculation 24 hours after full-thickness excisional wounding. The infection of the provisional wound matrix present at this time forestalls either rapid clearance or dissemination of infection and instead establishes chronic infection lasting 7-10 days without the need for implantation of foreign materials or immune suppression. This protocol mimics a typical temporal course of post-operative infection in humans. The use of a luminescent P. aeruginosa strain (PAO1:lux) allows for quantitative daily assessment of bacterial burden for P. aeruginosa wound infections. This novel model may be a useful tool in the investigation of bacterial pathogenesis and the development of new therapies for chronic P. aeruginosa wound infections.

Entities:  

Year:  2020        PMID: 32150161      PMCID: PMC7309497          DOI: 10.3791/60599

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  14 in total

1.  Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound model.

Authors:  Hannah Trøstrup; Kim Thomsen; Lars J Christophersen; Hans P Hougen; Thomas Bjarnsholt; Peter Ø Jensen; Nikolai Kirkby; Henrik Calum; Niels Høiby; Claus Moser
Journal:  Wound Repair Regen       Date:  2013-02-25       Impact factor: 3.617

2.  Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection.

Authors:  Johanna M Sweere; Jonas D Van Belleghem; Heather Ishak; Michelle S Bach; Medeea Popescu; Vivekananda Sunkari; Gernot Kaber; Robert Manasherob; Gina A Suh; Xiou Cao; Christiaan R de Vries; Dung N Lam; Payton L Marshall; Maria Birukova; Ethan Katznelson; Daniel V Lazzareschi; Swathi Balaji; Sundeep G Keswani; Thomas R Hawn; Patrick R Secor; Paul L Bollyky
Journal:  Science       Date:  2019-03-29       Impact factor: 47.728

Review 3.  Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.

Authors:  Marilee D Obritsch; Douglas N Fish; Robert MacLaren; Rose Jung
Journal:  Pharmacotherapy       Date:  2005-10       Impact factor: 4.705

Review 4.  Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  Raffaele Serra; Raffaele Grande; Lucia Butrico; Alessio Rossi; Ugo Francesco Settimio; Benedetto Caroleo; Bruno Amato; Luca Gallelli; Stefano de Franciscis
Journal:  Expert Rev Anti Infect Ther       Date:  2015-03-08       Impact factor: 5.091

5.  Human skin wounds: a major and snowballing threat to public health and the economy.

Authors:  Chandan K Sen; Gayle M Gordillo; Sashwati Roy; Robert Kirsner; Lynn Lambert; Thomas K Hunt; Finn Gottrup; Geoffrey C Gurtner; Michael T Longaker
Journal:  Wound Repair Regen       Date:  2009 Nov-Dec       Impact factor: 3.617

6.  Reduced neutrophil chemotaxis and infiltration contributes to delayed resolution of cutaneous wound infection with advanced age.

Authors:  Aleah L Brubaker; Juan L Rendon; Luis Ramirez; Mashkoor A Choudhry; Elizabeth J Kovacs
Journal:  J Immunol       Date:  2013-01-14       Impact factor: 5.422

7.  Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice.

Authors:  Chase Watters; Katrina DeLeon; Urvish Trivedi; John A Griswold; Mark Lyte; Ken J Hampel; Matthew J Wargo; Kendra P Rumbaugh
Journal:  Med Microbiol Immunol       Date:  2012-09-25       Impact factor: 3.402

8.  Time course study of delayed wound healing in a biofilm-challenged diabetic mouse model.

Authors:  Ge Zhao; Marcia L Usui; Robert A Underwood; Pradeep K Singh; Garth A James; Philip S Stewart; Philip Fleckman; John E Olerud
Journal:  Wound Repair Regen       Date:  2012 May-Jun       Impact factor: 3.617

9.  Interactions between polymorphonuclear leukocytes and Pseudomonas aeruginosa biofilms on silicone implants in vivo.

Authors:  Maria van Gennip; Louise Dahl Christensen; Morten Alhede; Klaus Qvortrup; Peter Østrup Jensen; Niels Høiby; Michael Givskov; Thomas Bjarnsholt
Journal:  Infect Immun       Date:  2012-05-14       Impact factor: 3.441

10.  The Immune Response to Chronic Pseudomonas aeruginosa Wound Infection in Immunocompetent Mice.

Authors:  Johanna M Sweere; Heather Ishak; Vivekananda Sunkari; Michelle S Bach; Robert Manasherob; Koshika Yadava; Shannon M Ruppert; Chandan K Sen; Swathi Balaji; Sundeep G Keswani; Patrick R Secor; Paul L Bollyky
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-12-18       Impact factor: 4.730

View more
  2 in total

1.  Filamentous bacteriophage delays healing of Pseudomonas-infected wounds.

Authors:  Michelle S Bach; Christiaan R de Vries; Arya Khosravi; Johanna M Sweere; Medeea C Popescu; Qingquan Chen; Sally Demirdjian; Aviv Hargil; Jonas D Van Belleghem; Gernot Kaber; Maryam Hajfathalian; Elizabeth B Burgener; Dan Liu; Quynh-Lam Tran; Tejas Dharmaraj; Maria Birukova; Vivekananda Sunkari; Swathi Balaji; Nandini Ghosh; Shomita S Mathew-Steiner; Mohamed S El Masry; Sundeep G Keswani; Niaz Banaei; Laurence Nedelec; Chandan K Sen; Venita Chandra; Patrick R Secor; Gina A Suh; Paul L Bollyky
Journal:  Cell Rep Med       Date:  2022-06-21

2.  High-Voltage, Pulsed Electric Fields Eliminate Pseudomonas aeruginosa Stable Infection in a Mouse Burn Model.

Authors:  Mengjie Wu; Andrey Ethan Rubin; Tianhong Dai; Rene Schloss; Osman Berk Usta; Alexander Golberg; Martin Yarmush
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-12-18       Impact factor: 4.947

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.